Trial intelligence / Profile preview

NIKITA: Anakinra vs IVIG in Kawasaki Disease

NCT06697431Phase 4Withdrawn

Sponsor
Meyer Children's Hospital IRCCS
Start
Apr 2026
Primary completion
Apr 2026
Modality
Cytokines & Interferons
01

Overview

A Phase 4 trial of anakinra in Kawasaki disease (KD), sponsored by Meyer Children's Hospital IRCCS. Planned start Apr 2026; status: withdrawn.

02

Drugs

anakinra
03

Conditions

Kawasaki disease (KD)

Beyond the preview

Go deeper on NCT06697431.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06697431.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call